¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦42Â÷ KSTH Ãá°èÇмú´ëȸ : 2023-05-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦42Â÷ KSTH Ãá°èÇмú´ëȸ : 2023-05-12
±³À°ÀÏÀÚ : 2023-05-12
±³À°Àå¼Ò : ¼­¿ï°¡µçÈ£ÅÚ 2F ±×·£µåº¼·ëȦ

±³À°ÁÖÁ¦ : Á¦42Â÷ KSTH Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 02-790-2426  

À̸ÞÀÏ : ksth@thrombo.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í ±âŸ 10,000

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 05¿ù 12ÀÏ È¦A 08:50~09:00 °³È¸»ç ()

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 09:00~09:25 Immune TTP : new therapeutic options and their optimal use ÀÌÁöÇö(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 09:00~09:25 Future of factor XI inhibitors for arterial thromboembolism ½Åµ¿È£(Àü³²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 09:25~09:50 TTP : Management following recovery from an acute episode and during remission ¾È¼­¿¬(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 09:25~09:50 Anticoagulation strategy in older patients with Atrial fibrillation ½ÉÀç¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 09:50~10:15 Complement of secondary TMA : pathophysiology and treatment È«ÁؽÄ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 09:50~10:15 Atrial fibrillation in acute myocardial infarction À§Áø(°¡ÃµÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦A 10:15~10:30 Discussion ±èÁø¼®,±è¼ºÇö(¿¬¼¼ÀÇ´ë, µ¿¾ÆÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦B 10:15~10:30 Discussion ¾È¿µ±Ù, ³ª»óÈÆ(Àü³²ÀÇ´ë, ¼­¿ïÀÇ´ë)

ÈÞ½Ä 05¿ù 12ÀÏ 10:30~10:45 coffee break ()

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 10:45~11:10 How to differentiate tumor thrombus or bland thrombus ³ª»óÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 10:45~11:10 Antiplatelet therapy in patients with thrombocytopenia or anemia Çã¾Ö¿µ(°­¿øÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 11:10~11:35 An update on risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses ȲÇå±Ô(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 11:10~11:35 Catheter-related arterial thrombosis & bleeding Á¶ÀÎÁ¤(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 11:35~12:00 Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia    ±è°æÇÏ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 11:35~12:00 Heparin-induced thrombocytopenia °­¹Î°æ(ÇѸ²ÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦A 12:00~12:15 Discussion ±è¾ç±â,ÃÖ¿øÀÏ(¼øõÇâÀÇ´ë, ¸íÁöº´¿ø)

Åä·Ð 05¿ù 12ÀÏ È¦B 12:00~12:15 Discussion Á¤¸íÈ£,À强¼ö(Àü³²ÀÇ´ë,¿ï»êÀÇ´ë)

½Ä»ç 05¿ù 12ÀÏ 12:15~13:15 Lunch ()

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 13:15~13:40 Emicizumab : lab issue ¹Ú»óÇõ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 13:15~13:40 Recent advances of immune thrombocytopenia Á¤Çظ²(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 13:40~14:05 vonwillebrand disease - Áø´Ü, ºÐ·ù, NGS ±è³²Èñ(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 13:40~14:05 Magement of thrombocytopenia associated with autoimmune disease Çö½Å¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 14:05~14:30 Rare bleeding disorders (VWD Á¦¿Ü, rare factor deficiency)  (FVII, FXI deficiency) Çѽ¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 14:05~14:30 Coagulopathy and Thrombocytopenia  in liver disease Àü¹ÎÁö(°í·ÁÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦A 14:30~14:45 Discussion À¯Ã¶¿ì,À¯Ã¶ÁÖ(À»ÁöÀÇ´ë, ¿¬¼¼ÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦B 14:30~14:45 Discussion À±¼º¼ö,¹®¿µÃ¶(¼­¿ïÀÇ´ë, ÀÌÈ­ÀÇ´ë)

ÈÞ½Ä 05¿ù 12ÀÏ 14:45~15:00 coffee break ()

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 15:00~15:25 New approaches to chemotherapy-induced thrombocytopenia ¹Ú¿µÈÆ(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 15:00~15:25 An Insight into Recent Advances on Platelet Function in Health and Disease ±è¼öÁ¾(ÃæºÏ´ë ¼öÀÇÇаú)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 15:25~15:50 Antiplatelet and anticoagulant therapy during the CIT period ÃÖ°­¿î(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 15:25~15:50 P-and E-selectin in venous thrombosis and non-venous pathologies ¹Ú¼³Èñ(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 15:50~16:15 Recurrence and bleeding complication of cancer-associated thrombosis ÀÌÁöÀ±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦B 15:50~16:15 Endothelial dysfunction in COVID-19 ±èº¸Çö(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 05¿ù 12ÀÏ È¦A 16:15~16:40 cancer-associated thrombosis management in patients with preexisting cardiovascular disease ±èÀº°æ(¼º±Õ°üÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦B 16:15~16:30 Discussion ¹Ú³ëÁø,¼ÛÀç¿ì(¼øõÇâÀÇ´ë,¿¬¼¼ÀÇ´ë)

Åä·Ð 05¿ù 12ÀÏ È¦A 16:40~16:50 panel discussion ½ÉÁö¿µ,Á¤¿ì¹é,ÀÓÈ£¿µ,ȲÇå±Ô(¿¬¼¼ÀÇ´ë, Ä«Å縯ÀÇ´ë,ÀüºÏÀÇ´ë,¼øõÇâÀÇ´ë)

±âŸ 05¿ù 12ÀÏ È¦A 16:50~16:55 Æóȸ½Ä ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦42Â÷ KSTH Ãá°èÇмú´ëȸ : 2023-05-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ KSBMB International Conference 2023(2ÀÏÂ÷) : 2023-05-12
´ÙÀ½±Û ´ëÇÑÃÊÀ½ÆÄÀÇÇÐȸ Á¦ 54Â÷ Çмú´ëȸ ( KSUM 2023)_Day2 : 2023-05-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 4 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 7 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 112 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 17 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 75 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 12 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 8 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 7 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 27 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 3 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 8 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 10 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 8 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 11 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷